pharma news today glp-1 today India's fast-growing weight-loss drug market is showing signs of moderation after a sharp surge in recent months. New data reveals that sales growth of semaglutide and therapies slowed Lilly is now pharma's top

The trial results are real

FeelGood GLP-1 2026 Research Explores Brand-Stated $149/Month Telehealth Access, Compounded Medication Disclosures, and Buyer Questions Why This Review Exists Right Now - and Why Timing Matters for GLP-1 Buyers in 2026 FDA has publicly identified concerns involving unapproved and compounded GLP-1 products, including dosing errors, improper storage during shipping, fraudulent compounded products, adverse-event reports, semaglutide salt forms, and illegal online sales

Is there evidence to support probiotic use for healthy people

The site is updated occasionally, but may not reflect the most up-to-date information

At this point in the therapy i have a large amount of scar tissue build up on the tendon, to the point of it being visible in the thickness of the tendon compared to the other elbow